首页|参附注射液治疗心肾阳虚型慢性心力衰竭急性加重的临床研究

参附注射液治疗心肾阳虚型慢性心力衰竭急性加重的临床研究

扫码查看
目的:观察参附注射液治疗心肾阳虚型慢性心力衰竭急性加重的临床疗效。方法:选取2023年10月-2024年1月在安徽中医药大学第一附属医院住院的慢性心力衰竭急性加重病人60例,按照随机数字表法分为观察组与对照组,各30例。观察组给予参附注射液加西医常规治疗,对照组仅给予西医常规治疗,比较两组治疗前后血浆氨基末端B型钠尿肽前体(NT-proBNP)、超敏肌钙蛋白l(hs-cTnl)、6 min步行试验(6MWT)、明尼苏达州心力衰竭生活质量问卷评分(MLHFQ)、中医证候积分及纽约心脏病协会(NYHA)心功能分级。结果:与治疗前比较,两组治疗后NT-proBNP、hs-cTnl水平降低(P<0。05),两组治疗后NT-proBNP、hs-cTnl水平比较差异均无统计学意义(P>0。05);与治疗前比较,两组治疗后6MWT、MLHFQ评分均明显改善(P<0。05),观察组改善程度优于对照组(P<0。05);两组治疗后各单项中医证候积分低于治疗前(P<0。05),观察组治疗后喘促气短、倦怠乏力、畏寒肢冷及言语声低评分低于对照组(P<0。05)。观察组总有效率为96。7%,对照组为80。0%,两组比较差异有统计学意义(P<0。05)。结论:参附注射液联合西药常规治疗可改善心肾阳虚型慢性心力衰竭急性加重病人心功能,提高病人运动耐量和生活质量。
Clinical Study of Shenfu Injection for Treating Acute Aggravation of Chronic Heart Failure with Heart-kidney Yang Deficiency
Objective:To observe the clinical effect of Shenfu injection on acute aggravation of chronic heart failure with heart-kidney Yang deficiency.Methods:Sixty patients with acute aggravation of chronic heart failure were selected and divided into observation group and control group according to random number table,with 30 cases in each group.Observation group was given Shenfu injection plus conventional western medicine treatment,control group was given only conventional western medicine treatment.N-terminal pro-B-type natriuretic peptide(NT-proBNP),high-sensitivity cardiac troponin l(hs-cTnl),six-minute walk test(6MWT),Minnesota Living with Heart Failure Questionnaire(MLHFQ)score,traditional Chinese medicine syndrome score,and New York Heart Association(NYHA)heart function grade were compared between the two groups before and after treatment.Results:Compared with before treatment,the levels of NT-proBNP and hs-cTnl decreased in two groups after treatment(P<0.05),and there were no statistical significance in the levels of NT-proBNP and hs-cTnl between the two groups after treatment(P>0.05).Compared with before treatment,6MWT and MLHFQ scores of both groups improved after treatment(P<0.05),and the improvement degree of observation group were better than that of the control group(P<0.05).After treatment,the scores of each single TCM syndrome in the two groups were lower than before treatment(P<0.05),and the scores of shortness of breath,fatigue,cold extremities,and low voice in the observation group were lower than those in the control group(P<0.05).The total effective rate was 96.7%in the observation group and 80.0%in the control group,and the difference between the two groups was statistically significant(P<0.05).Conclusion:Shenfu injection combined with conventional western medicine can improve the cardiac function,exercise tolerance and quality of life of patients with acute aggravation of heart-kidney Yang deficiency chronic heart failure

chronic heart failureheart-kidney Yang deficiencyacute aggravationShenfu injectionheart functiontraditional Chinese medicine syndrome

杨帆、冉永玲、彭聪、桂青、卢飚、袁良、黄平、戴小华

展开 >

安徽中医药大学第一附属医院(合肥 230031)

国家中医心血管病临床医学研究中心分中心(合肥 230031)

慢性心力衰竭 心肾阳虚 急性加重 参附注射液 心功能 中医证候

安徽省中医药高水平传承人才支持项目

皖中医药发展秘[2024]1号

2024

中西医结合心脑血管病杂志
中国中西医结合学会 山西医科大学第一医院

中西医结合心脑血管病杂志

CSTPCD
影响因子:1.463
ISSN:1672-1349
年,卷(期):2024.22(11)
  • 21